Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Identification of pathogenic GCK variants in patients with common type 2 diabetes can lead to discontinuation of pharmacological treatment.
Thuesen ACB, Jensen RT, Maagensen H, Kristiansen MR, Sørensen HT, Vaag A, Beck-Nielsen H, Pedersen OB, Grarup N, Nielsen JS, Rungby J, Gjesing AP, Storgaard H, Vilsbøll T, Hansen T. Thuesen ACB, et al. Among authors: maagensen h. Mol Genet Metab Rep. 2023 Mar 29;35:100972. doi: 10.1016/j.ymgmr.2023.100972. eCollection 2023 Jun. Mol Genet Metab Rep. 2023. PMID: 37008541 Free PMC article.
The Gut-Bone Axis in Diabetes.
Maagensen H, Helsted MM, Gasbjerg LS, Vilsbøll T, Knop FK. Maagensen H, et al. Curr Osteoporos Rep. 2023 Feb;21(1):21-31. doi: 10.1007/s11914-022-00767-2. Epub 2022 Nov 28. Curr Osteoporos Rep. 2023. PMID: 36441432 Review.
The glucagon receptor antagonist LY2409021 does not affect gastrointestinal-mediated glucose disposal or the incretin effect in individuals with and without type 2 diabetes.
Hædersdal S, Lund A, Nielsen-Hannerup E, Maagensen H, Forman JL, Holst JJ, Knop FK, Vilsbøll T. Hædersdal S, et al. Among authors: maagensen h. Eur J Endocrinol. 2022 Sep 12;187(4):507-518. doi: 10.1530/EJE-22-0291. Print 2022 Oct 1. Eur J Endocrinol. 2022. PMID: 35977072 Clinical Trial.
The Role of Glucagon in the Acute Therapeutic Effects of SGLT2 Inhibition.
Hædersdal S, Lund A, Nielsen-Hannerup E, Maagensen H, van Hall G, Holst JJ, Knop FK, Vilsbøll T. Hædersdal S, et al. Among authors: maagensen h. Diabetes. 2020 Dec;69(12):2619-2629. doi: 10.2337/db20-0369. Epub 2020 Oct 1. Diabetes. 2020. PMID: 33004472 Free PMC article.